Results 231 to 240 of about 76,053 (241)

A randomised multicentre phase II trial of capecitabine vs S-1 as first-line treatment in elderly patients with metastatic or recurrent unresectable gastric cancer

British Journal of Cancer, 2008
J-L Lee, K-H Lee, B-Y Ryoo
exaly  

Lower dose capecitabine has a more favorable therapeutic index in metastatic breast cancer: retrospective analysis of patients treated at M. D. Anderson Cancer Center and a review of capecitabine toxicity in the literature

Annals of Oncology, 2005
B T Hennessy, Gabriel N Hortobagyi
exaly  

Clinical outcome of patients with brain metastases from HER2-positive breast cancer treated with lapatinib and capecitabine

Annals of Oncology, 2011
Giulio Metro, J Foglietta, M Russillo
exaly  

Capecitabine

Reactions Weekly, 2008
openaire   +2 more sources

Multicenter phase II study of oral capecitabine (Xeloda“) in patients with metastatic breast cancer relapsing after treatment with a taxane-containing therapy

Annals of Oncology, 2003
P Reichardt, P C Thuss-Patience, D G Kieback   +2 more
exaly  

Anti-angiogenesis participates in antitumor effects of metronomic capecitabine on colon cancer

Cancer Letters, 2014
Jinling Jiang, Yingyan Yu, Bingya Liu
exaly  

Capecitabine

Reactions Weekly, 2014
openaire   +2 more sources

Slow dissolution behaviour of amorphous capecitabine

International Journal of Pharmaceutics, 2013
Jos H Beijnen, Jan H M Schellens
exaly  

Emergency use of uridine triacetate for the prevention and treatment of life‐threatening 5‐fluorouracil and capecitabine toxicity

Cancer, 2017
Wen Wee, Muhammad Wasif Saif, Bassel F El-Rayes   +2 more
exaly  

A phase II trial of capecitabine in previously untreated patients with advanced and/or metastatic gastric cancer

Annals of Oncology, 2004
Y S Hong, S Y Song, S I Lee
exaly